Literature DB >> 2258084

Uterine sarcoma: steroid receptors and response to hormonal therapy.

K Wade1, M A Quinn, I Hammond, K Williams, M Cauchi.   

Abstract

Seventy-three patients with uterine sarcomas were treated between 1976 and 1987. Steroid receptors were analyzed in 60 cases; 48% were estrogen receptor (ER) positive, and 30% progesterone receptor (PR) positive. Only 1 of 28 patients with residual or recurrent disease showed a response to hormonal therapy. Neither receptor status of the primary tumor nor use of adjuvant hormonal therapy affected survival.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2258084     DOI： 10.1016/0090-8258(90)90267-o

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


  9 in total

1.  Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.

Authors:  Keiko Shoji; Katsutoshi Oda; Shunsuke Nakagawa; Kei Kawana; Toshiharu Yasugi; Yuji Ikeda; Yutaka Takazawa; Shiro Kozuma; Yuji Taketani
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

2.  The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study.

Authors:  A C Ansink; P A Cross; P Scorer; A de Barros Lopes; J M Monaghan
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

3.  Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.

Authors:  Riitta Koivisto-Korander; Ralf Butzow; Anna-Maija Koivisto; Arto Leminen
Journal:  Tumour Biol       Date:  2010-12-16

4.  Contemporary management and classification of hepatic leiomyosarcoma.

Authors:  Mazin O Hamed; Keith J Roberts; William Merchant; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2014-11-24       Impact factor: 3.647

5.  Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.

Authors:  Roisin O'Cearbhaill; Qin Zhou; Alexia Iasonos; Robert A Soslow; Mario M Leitao; Carol Aghajanian; Martee L Hensley
Journal:  Gynecol Oncol       Date:  2009-11-24       Impact factor: 5.482

6.  Expression of androgen receptors in benign and malignant endometrial stromal neoplasms.

Authors:  Farid Moinfar; Peter Regitnig; Ali Dastranj Tabrizi; Helmut Denk; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2004-03-06       Impact factor: 4.064

7.  Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas.

Authors:  Juliane Briese; Heinrich M Schulte; Maria Sajin; Christoph Bamberger; Katja Redlin; Karin Milde-Langosch; Thomas Löning; Ana-Maria Bamberger
Journal:  Virchows Arch       Date:  2008-04-16       Impact factor: 4.064

8.  Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.

Authors:  Jeong-Yeol Park; Min-Hyun Baek; Yangsoon Park; Young-Tak Kim; Joo-Hyun Nam
Journal:  Virchows Arch       Date:  2018-06-04       Impact factor: 4.064

9.  Gonadotrophin-releasing hormone (GnRH) analogues in the treatment of mixed mullerian tumours of the uterus: two case reports and review.

Authors:  M Katesmark; F Lawton
Journal:  Sarcoma       Date:  1998
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.